Differential outcomes and immune checkpoint inhibitor response among endometrial cancer patients with MLH1 hypermethylation versus MLH1 “Lynch-like” mismatch repair gene mutation
Michael D. Toboni, Sharon Wu, Alex Farrell, Joanne Xiu, Jennifer R. Ribeiro, Matthew J. Oberley, Rebecca Arend, Britt K. Erickson, Thomas J. Herzog, Premal H. Thaker, Matthew A. Powell
Dive into the research topics of 'Differential outcomes and immune checkpoint inhibitor response among endometrial cancer patients with MLH1 hypermethylation versus MLH1 “Lynch-like” mismatch repair gene mutation'. Together they form a unique fingerprint.